Effect of Sertraline and Vortioxetine on Stress-Induced Brain Injury in Rats: Biochemical and Histopathological Evaluations
Özet
Objectives: Our aim was to evaluate the comparative effects of sertraline and vortioxetine against stress-induced brain injury in rats. Methods: The rats were assigned to a nonstress group (NSG), stress-treated control (StC), sertraline + stress (SSt), and vortioxetine + stress (VSt) groups. Sertraline and vortioxetine (10 mg/kg) were given orally by gavage to the SSt and VSt groups. One hour later, all animals (except NSG) underwent forced immobilization to establish a stress model (2 hours). The drugs were given once a day for 30 days. The animals were killed with ketamine 150 mg/kg, and tissues were removed from the cerebral cortex. One-way analysis of variance and Fisher post hoc least significant difference were conducted for the analysis. Results: The malondialdehyde (nmol/mL) level was 2.58 ± 0.48 in the NSG, 8.09 ± 0.57 in the StC, 3.84 ± 0.53 in the SSt, and 2.84 ± 0.20 in the VSt group (P < 0.0002). The total glutathione (mmol/g) was 7.15 ± 0.59 in the NSG, 2.41 ± 0.43 in the StC, 4.58 ± 0.26 in the SSt, and 5.98 ± 0.13 in the VSt (P < 0.0002). The total oxidant status (mmol H2O2Eq/L) level was 3.56 ± 0.20 in the NSG, 9.99 ± 0.74 in the StC, 4.97 ± 0.39 in the SSt, and 3.81 ± 0.31 in the VSt (P < 0.0002). The total antioxidant status (mmolTroloxEq/L) level was 8.65 ± 0.37 in the NSG, 3.04 ± 0.22 in the StC, 6.29 ± 0.34 in the SSt, and 7.61 ± 0.40 in the VSt (P < 0.0002). Sertraline reduced pericellular edema in astrocytes and oligodendrocytes and decreased perivascular edema, dilatation, and congestion of blood vessels, whereas these were not seen with vortioxetine. Conclusions: Compared with sertraline, vortioxetine is a neuroprotective antidepressant with higher antioxidant activity and can more effectively prevent stress-induced brain tissue injury. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Cim, Emine Fusun Akyuz | |
| dc.contributor.author | Suleyman, Zeynep | |
| dc.contributor.author | Suleyman, Halis | |
| dc.contributor.author | Yazici, Gulce Naz | |
| dc.contributor.author | Coban, Taha Abdulkadir | |
| dc.date.accessioned | 2026-10-18T20:26:07.690959718Z | |
| dc.date.available | 2026-10-18T20:26:07.690959718Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Objectives: Our aim was to evaluate the comparative effects of sertraline and vortioxetine against stress-induced brain injury in rats. Methods: The rats were assigned to a nonstress group (NSG), stress-treated control (StC), sertraline + stress (SSt), and vortioxetine + stress (VSt) groups. Sertraline and vortioxetine (10 mg/kg) were given orally by gavage to the SSt and VSt groups. One hour later, all animals (except NSG) underwent forced immobilization to establish a stress model (2 hours). The drugs were given once a day for 30 days. The animals were killed with ketamine 150 mg/kg, and tissues were removed from the cerebral cortex. One-way analysis of variance and Fisher post hoc least significant difference were conducted for the analysis. Results: The malondialdehyde (nmol/mL) level was 2.58 ± 0.48 in the NSG, 8.09 ± 0.57 in the StC, 3.84 ± 0.53 in the SSt, and 2.84 ± 0.20 in the VSt group (P < 0.0002). The total glutathione (mmol/g) was 7.15 ± 0.59 in the NSG, 2.41 ± 0.43 in the StC, 4.58 ± 0.26 in the SSt, and 5.98 ± 0.13 in the VSt (P < 0.0002). The total oxidant status (mmol H2O2Eq/L) level was 3.56 ± 0.20 in the NSG, 9.99 ± 0.74 in the StC, 4.97 ± 0.39 in the SSt, and 3.81 ± 0.31 in the VSt (P < 0.0002). The total antioxidant status (mmolTroloxEq/L) level was 8.65 ± 0.37 in the NSG, 3.04 ± 0.22 in the StC, 6.29 ± 0.34 in the SSt, and 7.61 ± 0.40 in the VSt (P < 0.0002). Sertraline reduced pericellular edema in astrocytes and oligodendrocytes and decreased perivascular edema, dilatation, and congestion of blood vessels, whereas these were not seen with vortioxetine. Conclusions: Compared with sertraline, vortioxetine is a neuroprotective antidepressant with higher antioxidant activity and can more effectively prevent stress-induced brain tissue injury. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved. | |
| dc.identifier.doi | 10.1097/wnf.0000000000000615 | |
| dc.identifier.eissn | 1537-162X | |
| dc.identifier.endpage | 217 | |
| dc.identifier.issn | 0362-5664 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 39792536 | |
| dc.identifier.scopus | 2-s2.0-85210353288 | |
| dc.identifier.startpage | 213 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11021 | |
| dc.identifier.volume | 47 | |
| dc.identifier.wos | WOS:001361328000002 | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams and Wilkins | |
| dc.relation.ispartof | Clinical Neuropharmacology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | antioxidant | |
| dc.subject | brain injury | |
| dc.subject | oxidant | |
| dc.subject | oxidative stress | |
| dc.subject | sertraline | |
| dc.subject | stress | |
| dc.subject | vortioxetine | |
| dc.subject | Animals | |
| dc.subject | Brain | |
| dc.subject | Brain Injuries | |
| dc.subject | Disease Models, Animal | |
| dc.subject | Glutathione | |
| dc.subject | Male | |
| dc.subject | Malondialdehyde | |
| dc.subject | Rats | |
| dc.subject | Rats, Sprague-Dawley | |
| dc.subject | Selective Serotonin Reuptake Inhibitors | |
| dc.subject | Stress, Psychological | |
| dc.subject | ketamine | |
| dc.subject | malonaldehyde | |
| dc.subject | serotonin uptake inhibitor | |
| dc.subject | animal cell | |
| dc.subject | animal experiment | |
| dc.subject | animal model | |
| dc.subject | animal tissue | |
| dc.subject | Article | |
| dc.subject | astrocyte | |
| dc.subject | brain biochemistry | |
| dc.subject | brain protection | |
| dc.subject | cerebral cortical tissue | |
| dc.title | Effect of Sertraline and Vortioxetine on Stress-Induced Brain Injury in Rats: Biochemical and Histopathological Evaluations | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 2 | |
| rdl.citation.wos | 1 | |
| rdl.department | Department of Nursing, Erzincan Binali Yıldırım University Faculty of Health Sciences. | Medical Biochemistry, Erzincan Binali Yıldırım University Faculty of Medicine, Erzincan, Turkey. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
